Abstract
Since the 1940s, the cryopreservation field has been deeply studied in order to increase the number of options available for human reproductive technologies. Initially, sperm cells were the only type to be preserved due to their size and high number available; these characteristics made the task relatively easy. Later on, with the advances made in the laboratories, embryo freezing became an available option in in vitro fertilization (IVF) clinics. In 1983, the first pregnancy was obtained from a cryopreserved embryo [1] and provided an important new option, influencing daily practice in the field of reproductive medicine. Consequently, the number of multiple pregnancies was significantly reduced and in the event that pregnancy was not achieved with a fresh cycle, cryopreserved embryos could be used in subsequent cycles without the need to undergo a new stimulation cycle. The overall efficiency was definitely improved. This new success pushed the clinicians further and the investigation on oocyte cryopreservation started. Initially, outcomes were not very encouraging, mainly because of the particular features of the oocyte compared to sperm or embryos. The oocyte, especially in the human, has unique composition in term of water content, membrane stability and intracellular structures. All of these characteristics made it very difficult to cryopreserve oocytes and for many years clinical applications have not been routinely adopted. The low survival rates and objectionable developmental competence of oocytes initially obtained after cryopreservation suggest that this technique could not be safely applied to patients. Moreover, the good results obtained with embryo cryopreservation were satisfying enough to limit research in the area of oocyte freezing for many years.
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsReferences
Trounson A, Mohr L. Human pregnancy following cryopreservation, thawing and transfer of an eight-cell embryo. Nature. 1983;305(5936):707–9.
Chen C. Pregnancy after human oocyte cryopreservation. Lancet. 1986;1:884–6.
Al-Hasani DK, van der Ven H, Reinecke A, et al. Cryopreservation of human oocytes Hum. Reproduction. 1987;2:695–700.
Porcu E, Fabbri R, Seracchioli R, et al. Birth of a healthy female after intracytoplasmic sperm injection of cryopreserved human oocytes. Fertil Steril. 1997;68(4):724–6.
Liu H, Lai Y, Davis O, et al. Improved pregnancy outcome with gonadotropin releasing hormone agonist stimulation is due to the improvement in oocyte quantity rather than quality. J Assist Reprod Genet. 1992;9:338–42.
Hugues JN, Barlow DH, Rosenwaks Z, et al. Improvement in consistency of response to ovarian stimulation with recombinant human follicle stimulating hormone resulting from a new method for calibrating the therapeutic preparation. Reprod BioMed Online. 2003;6:185–90.
Out HJ, David I, Ron-El R, et al. A randomized, double-blind clinical trial using fixed daily doses of 100 or 200 IU of recombinant FSH in ICSI cycles. Hum Reprod. 2001;16:1104–9.
Yong PY, Brett S, Baird DT, et al. A prospective randomized clinical trial comparing 150 IU and 225 IU of recombinant follicle-stimulating hormone (Gonal-F*) in a fixed-dose regimen for controlled ovarian stimulation in in vitro fertilization treatment. Fertil Steril. 2003;79:308–15.
Tesarik J, Mendoza C. Effects of exogenous LH administration during ovarian stimulation of pituitary down-regulated young oocyte donors on oocyte yield and developmental competence. Hum Reprod. 2002; 17:3129–37.
Dal Prato L, Borini A, Coticchio G, et al. Half-dose depot triptorelin in pituitary suppression for multiple ovarian stimulation in assisted reproduction technology: a randomized study. Hum Reprod. 2004;19: 2200–5.
Dal Prato L, Borini A, Travisi MR, et al. Effect of reduced dose of triptorelin at the start of ovarian stimulation on the outcome of IVF: a randomized study. Hum Reprod. 2001;16(7):1409–14.
Al-Inany HG, Abou-Setta AM, Aboulghar M. Gonadotropin-releasing hormone antagonists for assisted conception: a Cochrane review. Reprod Biomed Online. 2007;14(5):640–9.
Kolibianakis EM, Collins J, Tarlatzis BC, et al. Among patients treated for IVF with gonadotropins and GnRH analogues, is the probability of live birth dependent on the type of analogue used? A systematic review and meta-analysis. Hum Reprod Update. 2006;12(6): 651–71.
Al-Inany H, Aboulghar MA, Mansour RT, et al. Optimizing GnRH antagonist administration: meta-analysis of fixed versus flexible protocol. Reprod Biomed Online. 2005;10(5):567–70.
Patrizio P, Bianchi V, Lalioti M, et al. High rate of biological loss in assisted reproduction: it is in the seed, not in the soil. Reprod Biomd Online. 2007;14(1): 92–5.
Bedford JM, Kim HH. Sperm/oocyte binding patterns and oocyte cytology in retrospective analysis of fertilization failure in vitro. Hum Reprod. 1993;8:453–63.
Balaban B, Urman B, Sertac A, et al. Oocyte morphology does not affect fertilization rate, embryo quality and implantation rate after intracytoplasmic sperm injection. Hum Reprod. 1998;13:3431–3.
Serhal PF, Ranieri DM, Kinis M, et al. Oocyte morphology predicts outcome of intracytoplasmic sperm injection. Hum Reprod. 1997;12:1267–70.
Veeck LL. Oocyte assessment and biological performance. Ann NY Acad Sci. 1988;541:259–74.
Xia P. Intrcytoplasmic sperm injection: correlation of oocyte grade based on polar body, perivitelline space and cytoplasmic inclusions with fertilization rate and embryo quality. Human Reprod. 1997;12:1750–5.
Ebner T, Yaman C, Moser M, et al. Prognostic value of first polar body morphology on fertilization rate and embryo quality in intracytoplasmic sperm injection. Hum Reprod. 2000;15:427–30.
Ebner T, Moser M, Yaman C, et al. Prospective hatching of embryos developed from oocytes exhibiting difficult oolemma penetration during ICSI. Hum Reprod. 2002;17:1317–20.
Patrizio P, Fragouli E, Bianchi V, et al. Molecular methods for selection of the ideal oocyte. Reprod Biomed Online. 2007;15(3):346–53.
Kola I, Kirby C, Show J, et al. Vitrification of mouse oocytes results in aneuploid zygotes and malformed fetuses. Teratology. 1988;38:467–74.
Biery KA, Seidel Jr GE, Elsden RP. Cryopreservation of mouse embryos by direct plunging into liquid nitrogen. Theriogenology. 1986;25:140.
Shaw JM, Diotallevi L, Trounson AO. A simple rapid dimethyl suiphoxide freezing technique for the cryopreservation of one-cell to blastocyst stage preimplantation mouse embryos. Reprod Fertil Dev. 1991;3:621.
Rall WF, Fahy GM. Ice-free cryopreservation of mouse embryos at - 196°C vitrification. Nature. 1985; 313:573.
Gardner DK, Sheehan CB, Rienzi L, et al. Analysis of oocyte physiology to improve cryopreservation procedures. Theriogenology. 2007;67:64–72.
Yavin S, Arav A. Measurement of essential physical properties of vitrification solutions. Theriogenology. 2007;67(1):81–9.
Kono T, Kwon OY, Nakahara T. Development of vitrified mouse oocytes after in vitro fertilization. Cryobiology. 1991;28(1):50–4.
Liebermann J, Nawroth F, Isachenko V, et al. Potential importance of vitrification in reproductive medicine. Biol Reprod. 2002;67:1671–80.
Kuwayama M, Vajta G, Kato O, et al. Highly efficient vitrification method for cryopreservation of human oocytes. Reprod Biomed Online. 2005;11:300–8.
Vajta G, Nagy ZP. Are programmable freezers still needed in the embryo laboratory? Review on vitrification. Reprod Biomed Online. 2006;12(6):779–96.
Gualtieri R, Iaccarino M, Mollo V, et al. Slow cooling of human oocytes: ultrastructural injuries and apoptotic status. Fertil Steril. 2009;91:1023–34.
Gook DA, Osborn SM, Johnston WI. Cryopreservation of mouse and human oocytes using 1,2-propanediol and the configuration of the meiotic spindle. Hum Reprod. 1993;8:1101–9.
Nottola SA, Coticchio G, De Santis L, et al. Ultrastructural of human mature oocytes after slow cooling cryopreservation using different sucrose concentrations. Hum Reprod. 2007;22:1123–33.
Pickering SJ, Johnson MH. The influence of cooling on the organization of the meiotic spindle of the mouse oocyte. Hum Reprod. 1987;2:207–16.
Almeida PA, Bolton VN. The effect of temperature fluctuation on the cytoskeletal organisation and chromosomal constitution of the human oocyte. Zygote. 1995;3:357–65.
Cobo A, Rubio C, Gerli S, et al. Use of fluorescence in situ hybridization to assess the chromosomal status of embryos obtained from cryopreserved oocytes. Fertil Steril. 2001;75:354–60.
Sato H, Ellis GW, Inouè S. Microtubular origin of mitotic spindle from birefringence: demonstration of the applicability of Wiener’s equation. J Cell Biol. 1975;67:501–17.
Rienzi L, Ubaldi F, Martinez F, et al. Relationship between meiotic spindle location with regard to polar body position and oocyte developmental potential after ICSI. Hum Reprod. 2003;18:1289–93.
De Santis L, Cino I, Rabelotti E, et al. Polar body morphology and spindle imaging as predictors of oocyte quality. Reprod Biomed Online. 2005;11:36–42.
Madaschi C, Carvalho de Souza Bonetti T, Paes de Almeida Ferreira Braga D, et al. Spindle imaging: a marker for embryo development and implantation. Fertil Steril. 2008;90:194–8.
Wang WH, Meng L, Hackett RJ, et al. Developmental ability of human oocytes with or without birefringent spindles imaged by PoloScope before insemination. Hum Reprod. 2001;16:1464–8.
Wang WH, Meng L, Hackett RJ, et al. The spindle observation and its relationship with fertilization after intracytoplasmic sperm injection in living human oocytes. Fertil Steril. 2001;75:348–53.
Rienzi L, Martinez F, Ubaldi F, et al. Poloscope analysis of meiotic spindle changes in living metaphase II human oocytes during the freezing and thawing procedures. Hum Reprod. 2004;19:655–9.
Bianchi V, Coticchio G, Fava L, et al. Meiotic spindle imaging in human oocytes frozen with a slow freezing procedure involving high sucrose concentration. Hum Reprod. 2005;20(4):1078–83.
Bromfield JJ, Coticchio G, Hutt K, et al. Meiotic spindle dynamics in human oocytes following slow-cooling cryopreservation. Hum Reprod. 2009;24(9): 2114–23.
Coticchio G, De Santis L, Rossi G, et al. Sucrose concentration influences the rate of human oocytes with normal spindle and chromosome configuration after slow cooling cryopreservation. Hum Reprod. 2006; 21(7):1771–6.
Ciotti P, Porcu E, Notarangelo L, et al. Meiotic spindle recovery is faster in vitrification of human oocytes compared to slow freezing. Fertil Steril. 2009;91(6): 2399–407.
Parmigiani L, Cognigni GE, Bernardi S, et al. Freezing within 2 h from oocytes retrieval increases the efficiency of human oocyte cryopreservation when using slow freezing/rapid protocol with high sucrose concentration. Hum Reprod. 2008;23(8):1771–7.
Noyes N, Knopman J, Labella P, et al. Oocyte cryopreservation outcomes including pre-cryopreservation and post-thaw meiotic spindle evaluation following slow cooling and vitrification of human oocytes. Fertil Steril. 2010;94:2076–82.
Lassalle B, Testart J, Renard JP. Human embryo features that influence the success of cryopreservation with the use of 1,2 propanediol. Fertil Steril. 1985;44:645–51.
Borini A, Bonu MA, Coticchio G, et al. Pregnancies and births after oocyte cryopreservation. Fertil Steril. 2004;82:601–5.
Fabbri R, Porcu E, Marsella T, et al. Human oocyte cryopreservation: new perspectives regarding oocyte survival. Hum Reprod. 2001;16:411–6.
Borini A, Sciajno R, Bianchi V, et al. Clinical outcome of oocyte cryopreservation after slow cooling with a protocol utilizing a high sucrose concentration. Hum Reprod. 2006;21:512–7.
Levi Setti PE, Albani E, Novara PV, et al. Cryopreservation of supernumerary oocytes in IVF/ICSI cycles. Hum Reprod. 2006;21:370–5.
Bianchi V, Coticchio G, Distratis V, et al. Differential sucrose concentration during dehydration (0.2 mol/L) and rehydration (0.3 mol/L) increases the implantation rate of frozen human oocytes. Reprod Biomed Online. 2007;14:64–71.
Borini A, Levi Setti PE, Anserini P, et al. Multicenter observational study on slow-cooling oocyte cryopreservation: clinical outcome. Fertil Steril. 2010;94:1662–8.
Noyes N, Porcu E, Borini A. Over 900 oocyte cryopreservation babies born with no appearent increase in congenital anomalies. Reprod Biomed Online. 2009;18(6):769–76.
Kuleshova L, Gianaroli L, Magli C, et al. Birth following vitrification of a small number of human oocytes. Hum Reprod. 1999;14(12):3077–9.
Yoon T, Kim T, Park S, et al. Live births after vitrification of oocytes in a stimulated in vitro fertilization-embryo transfer program. Fertil Steril. 1993;79:1323–6.
Katayama KP, Stehlik J, Kuwayama M, et al. High survival rate of vitrified human oocytes results in clinical pregnancy. Fertil Steril. 2003;80:223–4.
Oktay K, Cil PA, Bang H. Efficiency of oocyte cryopreservation: a meta-analysis. Fertil Steril. 2006;86:70–80.
Antinori S, Licata E, Dani G, et al. Cryotop vitrification of human oocytes results in high survival rate and healthy deliveries. Reprod Biomed Online. 2007;14:72–9.
Cobo A, Kuwayama M, Perez S, et al. Comparison of concomitant outcome achieved with fresh and cryopreserved donor oocytes vitrified by the Cryotop method. Fertil Steril. 2008;89:1657–64.
Chian R-C, Huang J, Tan S, et al. Obstetric and perinatal outcome in 200 infants conceived from vitrified oocytes. Reprod BioMed Online. 2008;16:608–10.
Smith G, Serafini C, Fioravanti J, et al. Prospective randomized comparison of human oocyte cryopreservation with slow-rate freezing or vitrification. Fertil Steril. 2010;94:2088–95.
Grifo J, Noyes N. Delivery rate using cryopreserved oocytes is comparable to conventional in vitro fertilization using fresh oocytes: potential fertility preservation for female cancer patients. Fertil Steril. 2010;93(2):391–6.
Ubaldi F, Anniballo R, Romano S, et al. Cumulative ongoing pregnancy rate achieved with oocyte vitrification and cleavage stage transfer without embryo selection in a standard infertility program. Hum Reprod. 2010;25(5):1199–205.
Borini A, Bonu MA. Success rates from oocyte cryopreservation. In: Borini A, Coticchio G, editors. Preservation of human oocytes. London: Informa Healthcare; 2009. p. 235–45.
Toth TL, Baka SG, Veeck LL, et al. Fertilization and in vitro development of cryopreserved human prophase I oocytes. Fertil Steril. 1994;61:891–4.
Toth TL, Hassen WA, Lanzendorf SE, et al. Cryopreservation of human prophase I oocytes collected from unstimulated follicles. Fertil Steril. 1994;61:1077–82.
Demirtas E. Immature oocyte retrieval in the luteal phase to preserve fertility in cancer patients. Reprod Biomed Online. 2008;17(4):520–3.
Chian C, Huang J, Gilbert L, et al. Obstetric outcomes following vitrification of in vitro and in vivo matured oocytes. Fertil Steril. 2009;91(6):2391–8.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2012 Springer Science+Business Media, LLC
About this chapter
Cite this chapter
Borini, A., Bianchi, V. (2012). Oocyte Cryopreservation. In: Seli, E., Agarwal, A. (eds) Fertility Preservation. Springer, New York, NY. https://doi.org/10.1007/978-1-4419-1783-6_8
Download citation
DOI: https://doi.org/10.1007/978-1-4419-1783-6_8
Published:
Publisher Name: Springer, New York, NY
Print ISBN: 978-1-4419-1782-9
Online ISBN: 978-1-4419-1783-6
eBook Packages: MedicineMedicine (R0)